Rohit Kumar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rohit Kumar has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Deepak Kumar Sharma
Department of Pharmaceutical Engineering and Technology, IIT-Banaras Hindu, University, Varanasi, UP, India
8 shared publications - Pallavi Saha
Department of Pharmaceutical Engg. And Tech., IIT-Banaras Hindu University, Varanasi, UP, 221005, India
5 shared publications - Samarpita Das
Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology, Banaras Hindu University, Varanasi-221005, India
4 shared publications Arnab Roy
3 shared publications- Nitin Pal Kalia
Department of Biological Sciences (Pharmacology and Toxicology), National Institute of Pharmaceutical Education and Research, Hyderabad, Telangana, India
3 shared publications Avanish Yadav
Department of Pharmaceutical Engineering and Technology, IIT-Banaras Hindu, University, Varanasi, UP, India
2 shared publications
Latest Publications
- 4 November 2026
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 24 (42) , 8648-8652
PIDA/ammonium carbamate-mediated oxidative ring opening of indolizines to form pyridine-based acrylonitriles
A rapid oxidative ring-opening of indolizines using PIDA and ammonium carbamate affords pyridine-based acrylonitriles within 5 min in good to excellent yields.
- 4 November 2026
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 24 (42) , 8648-8652
PIDA/ammonium carbamate-mediated oxidative ring opening of indolizines to form pyridine-based acrylonitriles
A rapid oxidative ring-opening of indolizines using PIDA and ammonium carbamate affords pyridine-based acrylonitriles within 5 min in good to excellent yields.
- Open Access
- 6 August 2026
- Published by Elsevier in SSRN Electronic Journal
Quinoline-Mediated NDH-2 Inhibition Disrupts Redox Homeostasis and Bioenergetics in Mycobacterium tuberculosis
Mycobacterium tuberculosis (Mtb) possesses a highly flexible metabolic system that helps it to adapt, survive in the host. The type II NADH dehydrogenase, composed of two components, ndh and ndhA. is essential for survival of bacilli and its absence in humans makes it a promising druggable target. Here, we screened 10,000 drug like small molecules and shortlisted two molecules (64-9C and 64-9D) having quinoline scaffold, triggered a rapid ATP depletion, indicating interference with the electron transport chain. Structurally, 64-9C and 64-9D carry ester moieties at the 5- and 8-positions of the quinoline core, respectively. Based on ATP IC50 values and re-synthesisability, a focused library of 64-9D was subsequently synthesized, yielding compounds with MIC values of 0.25–4 μg/mL, consistent with ATP depletion. These compounds exhibited bactericidal activity against non-replicating mycobacteria and showed potent efficacy against multidrug-resistant (MDR) isolates and inhibit the purified recombinant NDH protein uncompetitively, even at minimal concentration. Altered, intracellular NADH/NAD+ ratio and inhibition of the oxygen consumption rate was indicative of oxidative phosphorylation inhibition. Selection of one step mutants revealed SNPs in gene encoding NDH-2. In-silico docking studies revealed that both 4FQN and 2FQN had good binding affinity with NDH-2 Interestingly, the series synergized with other ETC inhibitors. The derivative 2FQN exhibited dose-dependent bactericidal efficacy in mice, underscoring the potential of the series as a promising anti-tuberculosis candidates.
- 6 August 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessQuinoline-Mediated NDH-2 Inhibition Disrupts Redox Homeostasis and Bioenergetics in Mycobacterium tuberculosis
Mycobacterium tuberculosis (Mtb) possesses a highly flexible metabolic system that helps it to adapt, survive in the host. The type II NADH dehydrogenase, composed of two components, ndh and ndhA. is essential for survival of bacilli and its absence in humans makes it a promising druggable target. Here, we screened 10,000 drug like small molecules and shortlisted two molecules (64-9C and 64-9D) having quinoline scaffold, triggered a rapid ATP depletion, indicating interference with the electron transport chain. Structurally, 64-9C and 64-9D carry ester moieties at the 5- and 8-positions of the quinoline core, respectively. Based on ATP IC50 values and re-synthesisability, a focused library of 64-9D was subsequently synthesized, yielding compounds with MIC values of 0.25–4 μg/mL, consistent with ATP depletion. These compounds exhibited bactericidal activity against non-replicating mycobacteria and showed potent efficacy against multidrug-resistant (MDR) isolates and inhibit the purified recombinant NDH protein uncompetitively, even at minimal concentration. Altered, intracellular NADH/NAD+ ratio and inhibition of the oxygen consumption rate was indicative of oxidative phosphorylation inhibition. Selection of one step mutants revealed SNPs in gene encoding NDH-2. In-silico docking studies revealed that both 4FQN and 2FQN had good binding affinity with NDH-2 Interestingly, the series synergized with other ETC inhibitors. The derivative 2FQN exhibited dose-dependent bactericidal efficacy in mice, underscoring the potential of the series as a promising anti-tuberculosis candidates.
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
Visible-light-promoted C3-formylation of indolizines using glyoxylic acid and potassium persulfate in water
Visible-light-promoted C3-formylation of indolizines and imidazo[1,2- a ]pyridines was achieved using glyoxylic acid and potassium persulfate in water under photocatalyst-free conditions.
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
Visible-light-promoted C3-formylation of indolizines using glyoxylic acid and potassium persulfate in water
Visible-light-promoted C3-formylation of indolizines and imidazo[1,2- a ]pyridines was achieved using glyoxylic acid and potassium persulfate in water under photocatalyst-free conditions.
- 18 March 2025
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 16 (6) , 2808-2818
Indolylmaleimide derivatives as a new class of anti-leishmanial agents: synthesis and biological evaluation
We developed three series of indolylmaleimides using nucleophilic substitution with amines and amides via the Buchwald–Hartwig cross-coupling reaction. Compound 3m was found to exhibit potent anti-leishmanial activity against L. donovani parasites.
- 18 March 2025
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 16 (6) , 2808-2818
Indolylmaleimide derivatives as a new class of anti-leishmanial agents: synthesis and biological evaluation
We developed three series of indolylmaleimides using nucleophilic substitution with amines and amides via the Buchwald–Hartwig cross-coupling reaction. Compound 3m was found to exhibit potent anti-leishmanial activity against L. donovani parasites.
- 1 April 2024
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 48 (16) , 7041-7044
Persulfate promoted regioselective C-1 thiocyanation of imidazo[1,5- a ]pyridines under visible light irradiation in water
A visible light-mediated, photocatalyst-free, persulfate-promoted approach has been explored for regioselective C-1 thiocyanation of imidazo[1,5- a ]pyridines.
- 1 April 2024
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 48 (16) , 7041-7044
Persulfate promoted regioselective C-1 thiocyanation of imidazo[1,5- a ]pyridines under visible light irradiation in water
A visible light-mediated, photocatalyst-free, persulfate-promoted approach has been explored for regioselective C-1 thiocyanation of imidazo[1,5- a ]pyridines.
- 27 January 2024
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 15 (3) , 769-787
Cytochrome bd oxidase: an emerging anti-tubercular drug target
Cytochrome bd (cyt-bd) oxidase, one of the two terminal oxidases in the Mycobacterium tuberculosis (Mtb) oxidative phosphorylation pathway, plays an indispensable role in maintaining the functionality of the metabolic pathway under stressful conditions.
- 27 January 2024
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 15 (3) , 769-787
Cytochrome bd oxidase: an emerging anti-tubercular drug target
Cytochrome bd (cyt-bd) oxidase, one of the two terminal oxidases in the Mycobacterium tuberculosis (Mtb) oxidative phosphorylation pathway, plays an indispensable role in maintaining the functionality of the metabolic pathway under stressful conditions.
- 10 October 2023
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 21 (42) , 8471-8476
Visible light induced regioselective C-3 thiocyanation of imidazoheterocycles through naphthalimide dye based photoredox catalysis
A visible light induced C-3 thiocyanation of imidazo[1,2- a ]pyridines and various other heterocycles (benzo[ d ]imidazo[2,1- b ]thiazoles, indoles, azaindoles, and anilines) was performed using a naphthalimide based photoredox catalyst.
- 10 October 2023
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 21 (42) , 8471-8476
Visible light induced regioselective C-3 thiocyanation of imidazoheterocycles through naphthalimide dye based photoredox catalysis
A visible light induced C-3 thiocyanation of imidazo[1,2- a ]pyridines and various other heterocycles (benzo[ d ]imidazo[2,1- b ]thiazoles, indoles, azaindoles, and anilines) was performed using a naphthalimide based photoredox catalyst.